Neumora Therapeutics NMRA
NASDAQ NMRA
$0.42 -0.05 (-10.54%)
At close: Oct 21, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Non-Current Debt (2025 - 2026)

Updated

Neumora Therapeutics (NMRA) posted Non-Current Debt of $52.91 million for Q2 2026, up 172.0% from $19.45 million a year earlier but down 0.1% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Non-Current Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Neumora Therapeutics' Non-Current Debt came in at $54.53 million.

  • Quarterly Non-Current Debt has run from a low of $19.45 million in Q2 2025 to a high of $54.53 million in Q4 2025 over five years.
  • According to Business Quant data, Non-Current Debt for the three prior quarters was $52.96 million (Q1 2026), $54.53 million (Q4 2025) and $19.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 Neumora Therapeutics 78.88 Mn -539.08 Mn - 52.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.91 Mn
Mar 31, 2026 52.96 Mn
Dec 31, 2025 54.53 Mn
Sep 30, 2025 19.56 Mn
Jun 30, 2025 19.45 Mn
API Access

Neumora Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NMRA&period=max&api_key=YOUR_API_KEY